Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MS
van der Voort, L F, Vennegoor, A, Visser, A, Knol, D L, Uitdehaag, B M J, Barkhof, F, Oudejans, C B M, Polman, C H, Killestein, J
Published in Neurology (05.10.2010)
Published in Neurology (05.10.2010)
Get more information
Journal Article
Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis
Vosslamber, S, van der Voort, L F, van den Elskamp, I J, Heijmans, R, Aubin, C, Uitdehaag, B M J, Crusius, J B A, van der Pouw Kraan, T C T M, van der PouwKraan, T C T M, Comabella, M, Montalban, X, Hafler, D A, De Jager, P L, Killestein, J, Polman, C H, Verweij, C L
Published in Genes and immunity (01.09.2011)
Published in Genes and immunity (01.09.2011)
Get full text
Journal Article
Interferon-β bioactivity measurement in multiple sclerosis: feasibility for routine clinical practice
van der Voort, LF, Kok, A, Oudejans, CBM, Caldano, M, Gilli, F, Bertolotto, A, Polman, CH, Killestein, J
Published in Multiple sclerosis (01.02.2009)
Published in Multiple sclerosis (01.02.2009)
Get full text
Journal Article
Relevance of IL7R genotype and mRNA expression in Dutch patients with multiple sclerosis
Sombekke, MH, van der Voort, LF, Kragt, JJ, Nielsen, JM, Guzel, H, Visser, A, Oudejans, CBM, Crusius, JBA, Peña, A Salvador, Vrenken, H, Polman, CH, Killestein, J
Published in Multiple sclerosis (01.08.2011)
Published in Multiple sclerosis (01.08.2011)
Get full text
Journal Article
Erratum: Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonb therapy in multiple sclerosis
Vosslamber, S, van der Voort, L F, van den Elskamp, I J, Heijmans, R, Aubin, C, Uitdehaag, B M J, Crusius, J B A, van der Pouw Kraan, T C T M, Comabella, M, Montalban, X, Hafler, D A, De Jager, P L, Killestein, J, Polman, C H, Verweij, C L
Published in Genes and immunity (19.07.2012)
Published in Genes and immunity (19.07.2012)
Get full text
Journal Article
Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis
Published in Genes and immunity
(01.07.2012)
Get full text
Journal Article
Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonb therapy in multiple sclerosis
Vosslamber, S, Van Der Voort, L F, Van Den Elskamp, I J, Heijmans, R, Aubin, C, Uitdehaag, B M J, Crusius, J B A, Van Der Pouw Kraan, T C T M, Comabella, M, Montalban, X, Hafler, D A, De Jager, P L, Killestein, J, Polman, C H, Verweij, C L
Published in Genes and immunity (01.07.2012)
Published in Genes and immunity (01.07.2012)
Get full text
Journal Article
Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferon[beta] therapy in multiple sclerosis
Vosslamber, S, Van Der Voort, L F, Van Den Elskamp, I J, Heijmans, R, Aubin, C, Uitdehaag, B M J, Crusius, J B A, Van Der Pouwkraan, T C T M, Comabella, M, Montalban, X, Hafler, D A, De Jager, P L, Killestein, J, Polman, C H, Verweij, C L
Published in Genes and immunity (01.09.2011)
Published in Genes and immunity (01.09.2011)
Get full text
Journal Article
Neutralising antibodies against IFNb persist long after cessation of therapy
Van der Voort, LF, Gilli, F, Bertolotto, A, Knol, D L, Polman, C, Killestein, J
Published in Multiple sclerosis (01.09.2008)
Get full text
Published in Multiple sclerosis (01.09.2008)
Journal Article
Lack of interferon beta bioactivity is associated with the occurrence of relapses in multiple sclerosis
Van der Voort, LF, Visser, A, Oudejans, C B, Knol, D L, Polman, CH, Killestein, J
Published in Multiple sclerosis (01.09.2008)
Get full text
Published in Multiple sclerosis (01.09.2008)
Journal Article
Genetic variation in IFN signaling is associated with responsiveness to IFN-b in multiple sclerosis
Vosslamber, S, van der Voort, LF, van Baarsen, L, Heijmans, R, Crusius, JBA, Killestein, J, Polman, C, Verweij, CL
Published in Multiple sclerosis (01.09.2008)
Get full text
Published in Multiple sclerosis (01.09.2008)
Journal Article
Interferon-[beta] bioactivity measurement in multiple sclerosis: feasibility for routine clinical practice
van der Voort, LF, Kok, A, Oudejans, CBM, Caldano, M, Gilli, F, Bertolotto, A, Polman, CH, Killestein, J
Published in Multiple sclerosis (01.02.2009)
Published in Multiple sclerosis (01.02.2009)
Get full text
Journal Article